NCT01810549View on ClinicalTrials.gov

Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2013

Primary Completion Date

December 31, 2013

Conditions
Postprandial Fatigue
Interventions
DRUG

Anakinra

Each subject will receive one single subcutaneous injection of 100mg Anakinra during the study, a total of one injection.

DRUG

Placebo

Every subject will receive one single subcutaneous injection of Placebo during the study, a total of one injection.

Trial Locations (1)

4031

University Hospital Basel, Basel

All Listed Sponsors
lead

University of Zurich

OTHER

NCT01810549 - Role of Interleukin-1 in Postprandial Fatigue - The Cheesecake Study | Biotech Hunter | Biotech Hunter